Investing

Investors shouldn’t be discouraged by the recent price declines in battery-grade lithium, with expectations for growth in demand from the electric vehicle market still strong.“Currently, there is not enough lithium hydroxide being produced in the world to power the growing electric vehicles demand,” said Austin Devaney, chief commercial officer at…

It is our stance at the I/O Fund that the stock market is not logical, rather it’s sentimental. There is no logical explanation for a stock to go up 100% or more —— only to fall 40% or more in the matter of a couple of months. Fundamentals do not…

Last week, the S&P 500 produced multiple warning signs of a coming selloff. Was it what the Federal Reserve said? Likely, not. The breadth and depth of the indicators make them significant and serious. The backdrop Last week’s actions don’t stand alone. A negative backdrop has been forming since the…

By Stephen Nakrosis The American depositary receipts of Inventiva were trading higher in Wednesday’s after-hours market following news the biopharmaceutical company entered a licensing agreement with Hepalys to develop and commercialize Inventiva’s lanifibranor for the treatment of non-alcoholic steatohepatitis in Japan and South Korea. Inventiva has a 30% ownership position…

The Rales brothers, Steven M. Rales and Mitchell P. Rales, are renowned American businessmen and investors who have left an indelible mark on the corporate landscape, primarily through their association with Danaher DHR Corporation. Their journey to prominence began in the 1980s, when they, along with a group of investors,…

By Sabela Ojea Blue Owl Capital’s investment advisory firm Amergin Asset Management has acquired PNC Bank’s operating railcar portfolio. The capital market company said Wednesday that PNC Bank’s portfolio includes more than 6,000 railcars under management, which are leased to several companies across the U.S. PNC will continue to provide…

When I explain the appeal of closed-end funds (CEFs), I usually start with the big headline and throw a few bullets afterwards, kind of like this: CEFs yield an average 8%, and many of those dividends are sustainable and growing. CEFs invest in a variety of reliable and popular assets,…

By Stephen Nakrosis Kezar Life Sciences shares were trading higher in Wednesday’s after-hours market, following the entry of an agreement with biotechnology company Everest Medicines to develop and commercialize Zetomipzomib for lupus nephritis and other potential indications in Asia. Under the terms of the deal, Kezar is eligible to receive…

© 2024 Finances Smart. All Rights Reserved.